Therefore, we concluded that decreased serum TSAT levels and reduced hepatic hepcidin expression indicate decreased systemic iron status and hepatic iron dysregulation in NAFLD, which might provide additional information on biomarkers for the diagnosis of NAFLD. The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatotic liver disease.